• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The roles of Lats1/2 kinases in a stepwise EMT-MET switching mechanism of malignant tumor cells.

Research Project

Project/Area Number 17K07167
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Tumor biology
Research InstitutionOsaka University

Principal Investigator

Yabuta Norikazu  大阪大学, 微生物病研究所, 准教授 (10343245)

Project Period (FY) 2017-04-01 – 2020-03-31
Project Status Completed (Fiscal Year 2019)
Budget Amount *help
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2019: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2018: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2017: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Keywords口腔扁平上皮癌 / 上皮間葉転換 / 細胞増殖 / 悪性化 / Hippo経路 / LATS / リン酸化 / TGF-β / 癌 / シグナル伝達
Outline of Final Research Achievements

The epithelial-to-mesenchymal transition (EMT) is an essential process by which cancer cells acquire malignant features. However, the molecular mechanism and functional implications of the EMT and the mesenchymal-to-epithelial transition (MET) in tumor progression remain unclear. In this study, two aggressive cancer cell lines, mesenchymal-like Delta-SAS and epithelial-like SAS-δ, were established from oral cancer cells. SAS-δ, but not parental SAS, exhibited piled-up overgrowth and invasive tumor formation in the tongues of nude mice, suggesting that SAS-δ represented more advanced cancer cells than the parental SAS cells. The EMT-related transcriptional factor SLUG is phosphorylated by the Hippo pathway-related kinases, LATS1 and LATS2, and knockdown of SLUG by siRNA promoted the invasive activity of SAS-δ. Our results suggest that LATS1/2-SLUG axis regulates the transition of SAS cells to the advanced stage via repeated switching between the EMT and MET.

Academic Significance and Societal Importance of the Research Achievements

癌治療における最大の障壁は癌細胞の進展(悪性化)による浸潤・転移と、薬剤耐性能や放射線耐性能を獲得した癌幹細胞に由来するとされる癌の再発である。上皮間葉転換(EMT)と間葉上皮転換(MET)は浸潤転移や幹細胞化を誘導するため、悪性癌細胞の成り立ちや分子機序を理解する上で重要な細胞内機構の一つである。本研究の成果は、癌細胞がEMTとMETを連続的に繰り返すことによりさらに悪性度が高い癌細胞に形質転換する分子機構を解明し、これを標的とした新しい癌診断法や画期的な治療法の開発に繋がるものである。

Report

(4 results)
  • 2019 Annual Research Report   Final Research Report ( PDF )
  • 2018 Research-status Report
  • 2017 Research-status Report
  • Research Products

    (7 results)

All 2019 2018 2017

All Journal Article (3 results) (of which Int'l Joint Research: 1 results,  Peer Reviewed: 3 results,  Open Access: 2 results) Presentation (3 results) Book (1 results)

  • [Journal Article] Clathrin heavy chain phosphorylated at T606 plays a role in proper cell division2019

    • Author(s)
      Yabuno Yusuke、Uchihashi Toshihiro、Sasakura Towa、Shimizu Hiroyuki、Naito Yoko、Fukushima Kohshiro、Ota Kaori、Kogo Mikihiko、Nojima Hiroshi、Yabuta Norikazu
    • Journal Title

      Cell Cycle

      Volume: 18 Issue: 16 Pages: 1976-1994

    • DOI

      10.1080/15384101.2019.1637201

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed
  • [Journal Article] LATS1/2 kinases trigger self-renewal of cancer stem cells in aggressive oral cancer.2019

    • Author(s)
      Nozaki M, Yabuta N, Fukuzawa M, Mukai S, Okamoto A, Sasakura T, Fukushima K, Naito Y, Longmore GD, Nojima H.
    • Journal Title

      Oncotarget

      Volume: 10 Issue: 10 Pages: 1014-1030

    • DOI

      10.18632/oncotarget.26583

    • Related Report
      2018 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Isolation of cancer cells with augmented spheroid-forming capability using a novel tool equipped with removable filter.2018

    • Author(s)
      Fujibayashi E, Yabuta N, Nishikawa Y, Uchihashi T, Miura D, Kurioka K, Tanaka S, Kogo M, Nojima H.
    • Journal Title

      Oncotarget

      Volume: 9 Issue: 74 Pages: 33931-33946

    • DOI

      10.18632/oncotarget.26092

    • Related Report
      2018 Research-status Report
    • Peer Reviewed / Open Access
  • [Presentation] O-GlcNAc修飾は悪性中皮種の腫瘍進展を促進する2019

    • Author(s)
      向井智美、佐藤龍洋、三城恵美、青木正博、藪田紀一、関戸好孝
    • Organizer
      第78回日本癌学会学術総会
    • Related Report
      2019 Annual Research Report
  • [Presentation] 悪性中皮種においてLATS2はO-GlcNAc化を抑制する2018

    • Author(s)
      向井智美、佐藤龍洋、三城(佐藤)恵美、青木正博、藪田紀一、関戸好孝
    • Organizer
      第77回日本癌学会学術総会
    • Related Report
      2018 Research-status Report
  • [Presentation] LATSとSLUGはEMT-MET誘導性螺旋状悪性化メカニズムを制御する2017

    • Author(s)
      藤林えみ、向井智美、内橋俊大、田中晋、古郷幹彦、藪田紀一
    • Organizer
      第76回日本癌学会学術総会
    • Related Report
      2017 Research-status Report
  • [Book] 決定版 阻害剤・活性化剤ハンドブック2019

    • Author(s)
      藪田紀一(分担)(秋山徹、河府和義 編)
    • Total Pages
      648
    • Publisher
      羊土社
    • ISBN
      9784758120999
    • Related Report
      2019 Annual Research Report

URL: 

Published: 2017-04-28   Modified: 2021-02-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi